Showcasing more pharmaceutical and biopharmaceutical innovation, technology and knowledge, INTERPHEX (International Pharmaceutical Expo), premier pharmaceutical and biopharmaceutical development and manufacturing event dedicated to innovation, technology and knowledge will be unfolding at Jacob Javits Convention Center, New York from April 26-28, 2016.
With more than 10,000 attendees expected from 48 countries, this year’s trade show and conference offers key networking opportunities for pharmaceutical professionals from virtually every segment of the industry.
According to organizers, pharmaceutical professionals in attendance will include representatives from general management, facilities operations, project management, research development and formulation, the engineering community, business development, plant management, quality control, product manufacturing, facilities design, process development, regulatory affairs, and continuous quality verification.
INTERPHEX, sponsored by Parenteral Drug Association (PDA), is a leading annual industry event dedicated to showcasing pharmaceutical and biopharmaceutical innovation, technology and knowledge throughout the product development life cycle. It brings over 10,000 global pharmaceutical and biotechnology professionals together with more than 625 suppliers through a unique combination of exhibition, education, workshops, partnering opportunities, and networking events providing access to the industry and pharmaceutical, biotechnology and medical device global market. In fact the show focuses on the entire product development life cycle.
INTERPHEX is the only meeting place where innovation, technologies and knowledge and intersect with the full spectrum of cutting-edge development and manufacturing services and equipment to create innovative solutions that reduce cost and improve manufacturing and supply chain performance for pharmaceutical, biologics, contract, generic and service provider professionals.
New for 2016 include Pharmaceutical Technology’s Keynote Series, Return to Technical Conference via Call for Papers and DME’s Facility Focus.
About 300,000sf of event space will be offering state-of-the-art Innovation, Technologies and Knowledge. Industry leaders and subject matter experts from more than 48 countries will provide a unique opportunity to share their extensive knowledge of cutting-edge technologies.
This year's event will have more pharmaceutical, biotechnology and medical device innovation and technologies, more state-of-the-art technologies launches than ever before and more hours of Free Full Product Life Cycle Technical Education via PDA right on the Show Floor.
The event will include combination products, contract/ generics manufacturing, biosimilars, clinical materials, investigational products, nutraceuticals, compounding, API, 3D printing and technical consulting
Interphex Live will feature a number of the best and brightest leaders in the industry. These subject-matter experts will be discussing the latest trends and technologies on topics such as:
Biosimilars, Continuous processing, Preparing for FDA audits, Medicine authenticity, Capsule dosing, Overcoming facility upgrade challenges as well as many more topics.
Top exhibiting companies at INTERPHEX, according to the official website, include:AES; ASI; Azzur; Bausch & Stroebel; Cozzoli; CRB; Elizabeth Companies; EMD Millipore; Emerson Process Management; Fette Compacting America; Freund-Vector; GE Healthcare; Glatt; groninger; IMA Life; ILC Dover; IPS; KORSCH America; Korber Medipak; LB Bohle; M&W; MG America; Meissner Filtration; NJM Packaging; OSC Checkweighers; OPTIMA; Pall Life Sciences; Rommelag; Saint-Gobain; Sani-Matic; Sanofi Pasteur; Servolift; SKAN; Steris Corp.; Thermo Fisher-Scientific; Thomas Engineering; Walker Barrier Systems; and Whitehouse Laboratories.
Top attending companies expected at this year’s INTERPHEX include: 3M Company; AAI Pharma; AbbVie; Abbott; Actavis; Alexion; Amgen; Amneal; AstraZeneca; Bausch & Lomb; Baxter Healthcare; Bayer; Bigoen Idec; Boehringer Ingelheim; Bristol-Myers Squibb; Catalent Pharma; Celgene; Corepharma; Eli Lilly; Emergent; Biosolutions; Estee Lauder; Genentech; Genzyme; GlaxoSmithKline; Halo; Hi-Tech; Integra; Johnson & Johnson; Laureate Biopharmaceutical; Luitpold; MannKind; McNeil; Medimmune; Merck; Mylan; Novartis; Ohm; PAR; Parker-Hannifin; Perrigo; Pfizer; Prolong; Reckitt Benckiser; Regeneron; Roche; Sandoz; Sanofi Pasteur; Shire; Teva; URL Pharma; and W.L. Gore & Assoc. Inc.
INTERPHEX 2015, a big draw
INTERPHEX 2015 event was lauded by attendees and exhibitors as a resounding success. Attendees gathered to see first hand more than 1,200 exhibiting brands and new cutting-edge educational programming provided at the PDA Learning Center and the INTERPHEX
Connects Innovation Stages. The event held from April 21-23 at the Jacob K. Javits Center drew 14 per cent more pharmaceutical engineering professionals over the previous year.
According to an analyst, single-use systems and biotherapeutics were hot topics at INTERPHEX 2015. “This year’s INTERPHEX was one of the highest levels of activity I’ve seen in a decade,” he said. “Single-use technology is transforming the industry, and the resurgence in biotechnology capital raising and stronger pharmaceutical spending will provide a decade of faster growth for the industry.”
While multi-use stainless steel has long been the standard for material containment in pharmaceutical production, single-use technology such as disposable liner systems are on the rise as processors look to take advantage of cost and time savings, and reduce the issues of cross contamination. At INTERPHEX 2015, exhibitors such as Thermo Fisher Scientific, EMD Millipore and Pall Life Sciences showcased a number of single-use and flexible facilities technologies at their respective booths.
Oral solid dosage (OSD) forms continue to be a common and convenient method of drug delivery. On the pharmaceutical manufacturing front, Fette Compacting showcased its new FE75 double-sided rotary press that can produce more than 1.6 million tablets per hour. At INTERPHEX 2015, the company’s FE series of tablet presses were showcased together for the first time in North America. KORSCH America also launched the XT600 high-speed double rotary press, offering a new standard in high-volume production, while L. B. Bohle showcased a fleet of tablet coaters from laboratory through pilot to production scale.
Other themes underscored at INTERPHEX 2015 included modular aseptic barrier isolation, which was shown by SKAN US, as well as biotherapeutics from Thermo Fisher Scientific, EMD Millipore, GE Healthcare Life Sciences and Repligen.
IPS, in partnership with Pharmaceutical Processing, hosted a number of Technology Tours during INTERPHEX for the fifth consecutive year. INTERPHEX 2015 provided IPS with a unique venue to show its customers firsthand the latest technologies and equipment that can improve their operations.
In 2015, INTERPHEX expanded its show footprint to accommodate a considerable increase in cutting-edge technologies, products and value-added services to be showcased at the 2015 event. More than 30 leading technology suppliers decided to expand their exhibit space and bring more, new technology and equipment to the show floor.
SKAN US, Inc., a subsidiary of SKAN AG Switzerland and the world’s largest provider of isolator technology, showcased its flexible Pharmaceutical Safety Isolator L-Flange System (PSI-L) at INTERPHEX.